eGene Plan to Launch Complete Solution for Fast and Low-Cost Bird Flu Screening Through Distribution Agreement with Veredus Labs, Singapore for Its AIV-H5N1

eGene Inc., developer of a revolutionary high-performance genetic analysis technology, today announced that it plans to launch a complete solution for fast and low-cost bird flu screening by entering into a distribution agreement with Veredus Labs, Singapore for AIV-H5N1 PCR Kit Using eGene's HDA-GT12 System.

Ming S. Liu, CEO of eGene, made the announcement noting: "We are entering an agreement with Veredus Labs, Singapore to apply its AIV-H5N1 PCR kit with our HDA-GT12 system. Our previous testing results indicated that the HDA system, in combination with this single step RT-PCR assay, is a simple and sensitive assay for H5N1 avian influenza detection that can detect as few as 10 copies of the viral RNA. A total of 96 samples can be analyzed in less than 50 minutes. Initially, we believe a fast, sensitive and low-cost analysis to identify the contamination of the viral RNA in the poultry market can be one of the key factors to prevent the mass spread of the virus."